Vaxcyte Inc
Vaxcyte Inc logo
PCVX

Vaxcyte Inc (PCVX)

$44.661.5%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$43.61
Day's Range
$47.52
$16.78
52-Week Range
$46.57
1 month return1.48%
3 month return57.71%
1 year return122.11%
5 year return108.43%

Company Information

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte’s lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains, including newly emerging strains responsible for IPD and antibiotic resistance; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.
OrganizationVaxcyte Inc
Employees89
CEOMr. Grant E. Pickering M.B.A.
IndustryHealth Technology

Analyst Recommendation

based on 5 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for Vaxcyte Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 39.9%

Current

$44.46

Target

$62.2

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
5
10
10
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
3.5B
Book Value
$5.93
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.2
Wall Street Target Price
62.2

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
9.71
Enterprise Value
3.1B
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-18.96

Technicals

Beta
1.12
50 Day MA
32.93
200 Day MA
26.17

Institutional Holdings

FMR Inc

10.86%

RA Capital Management, LLC

5.84%

HHG PLC

5.79%

Abingworth LLP

5.32%

Vanguard Group Inc

5.05%

TPG GP A, LLC

4.68%

Discover more

Frequently Asked Questions

What is Vaxcyte Inc share price today?

Can Indians buy Vaxcyte Inc shares?

How can I buy Vaxcyte Inc shares from India?

Can Fractional shares of Vaxcyte Inc be purchased?

What are the documents required to start investing in Vaxcyte Inc stocks?

What are today’s High and Low prices of Vaxcyte Inc?

What are today’s traded volumes of Vaxcyte Inc?

What is today’s market capitalisation of Vaxcyte Inc?

What is the 52 Week High and Low Range of Vaxcyte Inc?

How much percentage Vaxcyte Inc is down from its 52 Week High?

How much percentage Vaxcyte Inc is up from its 52 Week low?

What are the historical returns of Vaxcyte Inc?

Who is the Chief Executive Officer (CEO) of Vaxcyte Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*